Sintx Technologies signs supply agreement with EVONIK

SINTX Technologies (SINT) signed a supply agreement with Evonik to manufacture the Company’s proprietary silicon nitride-PEEK compound engineered for AI-assisted additive manufacturing of patient-specific implants that will be produced using equipment already in place at SINTX’s U.S.-based production facility. Under the agreement, EVONIK will produce SiN/PEEK compound leveraging its commercial-scale capability to SINTX’s specifications, enabling the Company to immediately begin manufacturing AI-designed, 3D-printed, patient-specific implants. SINTX has already received physician requests to provide humanitarian-use vertebral body replacement implants for orthopedic and neurosurgical oncology patients following tumor resections in the spine. In addition, the Company intends to use the SiN/PEEK compound to support regulatory clearances of patient matched and traditional subtractive manufactured implantable devices.